Avermectins with a wide range of novel C-25 substituents have been prepared by feeding carboxylic acids or their biosynthetic precursors to a Streptomyces avermitilis mutant strain ATCC 53568. This organism lacks the ability to form isobutyric and S-2-methylbutyric acids from their 2-oxo acid precursors and thus is unable to produce natural avermectins unless supplied with these acids. The novel avermectins produced by mutational biosynthesis possess broad-spectrum antiparasitic activity.
Various strains of D. concentrica have been studied in laboratory cultures and a series of aromatic metabolites has been isolated, including benzene derivatives with a C, or C, side-chain, such as the chromanone (V) (shown to be derived from acetate or a related compound), and mono-and di-methyl ethers of 1,8-dihydroxynaphthalene. Non-enzymic oxidation of 1,8-dihydroxynaphthalene has also been investigated. The combined evidence suggests that in the fungus the C , , benzene derivatives and 1,8-dihydroxynaphthalene are alternative metabolites of a common acetate-derived precursor, and that alternative metabolic fates of the 1,s-dihydroxynaphthalene are methylation and oxidation, by way of the binaphthyl (I) to polymeric quinones and the perylenequinone (II), as previously described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.